Annual Net Income
-$93.61 M
+$26.80 M+22.25%
31 December 2023
Summary:
Immunic annual net profit is currently -$93.61 million, with the most recent change of +$26.80 million (+22.25%) on 31 December 2023. During the last 3 years, it has fallen by -$49.59 million (-112.67%). IMUX annual net income is now -1492.31% below its all-time high of -$5.88 million, reached on 31 December 2011.IMUX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$24.37 M
-$2.99 M-13.98%
30 September 2024
Summary:
Immunic quarterly net profit is currently -$24.37 million, with the most recent change of -$2.99 million (-13.98%) on 30 September 2024. Over the past year, it has dropped by -$1.60 million (-7.02%). IMUX quarterly net income is now -6084.77% below its all-time high of -$394.00 thousand, reached on 31 December 2012.IMUX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$96.90 M
-$1.60 M-1.68%
30 September 2024
Summary:
Immunic TTM net profit is currently -$96.90 million, with the most recent change of -$1.60 million (-1.68%) on 30 September 2024. Over the past year, it has increased by +$31.61 million (+24.60%). IMUX TTM net income is now -3538.90% below its all-time high of -$2.66 million, reached on 30 September 2012.IMUX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMUX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.3% | -7.0% | +24.6% |
| 3 y3 years | -112.7% | -26.3% | -16.9% |
| 5 y5 years | -125.7% | -196.6% | -226.2% |
IMUX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -112.7% | +22.3% | -26.3% | +56.9% | -22.3% | +24.6% |
| 5 y | 5 years | -168.0% | +22.3% | -216.8% | +56.9% | -226.2% | +24.6% |
| alltime | all time | -1492.3% | +22.3% | -6084.8% | +56.9% | -3538.9% | +24.6% |
Immunic Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.37 M(+14.0%) | -$96.90 M(+1.7%) |
| June 2024 | - | -$21.38 M(-27.7%) | -$95.31 M(-2.7%) |
| Mar 2024 | - | -$29.58 M(+37.1%) | -$97.92 M(+4.6%) |
| Dec 2023 | -$93.61 M(-22.3%) | -$21.57 M(-5.3%) | -$93.61 M(-27.2%) |
| Sept 2023 | - | -$22.77 M(-5.1%) | -$128.51 M(+1.2%) |
| June 2023 | - | -$24.00 M(-5.0%) | -$126.97 M(+1.7%) |
| Mar 2023 | - | -$25.27 M(-55.3%) | -$124.87 M(+3.7%) |
| Dec 2022 | -$120.41 M(+29.5%) | -$56.47 M(+166.1%) | -$120.41 M(+41.5%) |
| Sept 2022 | - | -$21.22 M(-3.1%) | -$85.12 M(+2.3%) |
| June 2022 | - | -$21.90 M(+5.3%) | -$83.19 M(+5.0%) |
| Mar 2022 | - | -$20.81 M(-1.8%) | -$79.22 M(-14.8%) |
| Dec 2021 | -$92.94 M(+111.2%) | -$21.18 M(+9.8%) | -$92.94 M(+12.1%) |
| Sept 2021 | - | -$19.29 M(+7.6%) | -$82.92 M(+8.3%) |
| June 2021 | - | -$17.93 M(-48.1%) | -$76.54 M(+9.2%) |
| Mar 2021 | - | -$34.53 M(+209.5%) | -$70.06 M(+59.2%) |
| Dec 2020 | -$44.02 M(+26.0%) | -$11.16 M(-13.6%) | -$44.02 M(+8.6%) |
| Sept 2020 | - | -$12.91 M(+12.7%) | -$40.55 M(+13.1%) |
| June 2020 | - | -$11.46 M(+35.0%) | -$35.85 M(-8.3%) |
| Mar 2020 | - | -$8.49 M(+10.3%) | -$39.11 M(+11.9%) |
| Dec 2019 | -$34.93 M(-15.8%) | -$7.69 M(-6.4%) | -$34.93 M(+17.6%) |
| Sept 2019 | - | -$8.21 M(-44.2%) | -$29.71 M(-11.1%) |
| June 2019 | - | -$14.71 M(+241.2%) | -$33.43 M(+6.5%) |
| Mar 2019 | - | -$4.31 M(+75.0%) | -$31.40 M(-24.3%) |
| Dec 2018 | -$41.48 M | -$2.46 M(-79.4%) | -$41.48 M(-22.6%) |
| Sept 2018 | - | -$11.94 M(-5.8%) | -$53.60 M(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$12.68 M(-11.9%) | -$54.14 M(+0.5%) |
| Mar 2018 | - | -$14.39 M(-1.4%) | -$53.86 M(+3.4%) |
| Dec 2017 | -$52.08 M(+27.1%) | -$14.59 M(+16.9%) | -$52.08 M(+5.8%) |
| Sept 2017 | - | -$12.48 M(+0.6%) | -$49.22 M(+4.9%) |
| June 2017 | - | -$12.41 M(-1.5%) | -$46.92 M(+6.7%) |
| Mar 2017 | - | -$12.60 M(+7.4%) | -$43.98 M(+7.4%) |
| Dec 2016 | -$40.97 M(-21.2%) | -$11.73 M(+15.3%) | -$40.97 M(+4.8%) |
| Sept 2016 | - | -$10.18 M(+7.5%) | -$39.09 M(-5.1%) |
| June 2016 | - | -$9.47 M(-1.3%) | -$41.22 M(-12.0%) |
| Mar 2016 | - | -$9.59 M(-2.7%) | -$46.85 M(-9.9%) |
| Dec 2015 | -$52.02 M(+9.1%) | -$9.86 M(-19.8%) | -$52.02 M(-7.3%) |
| Sept 2015 | - | -$12.30 M(-18.6%) | -$56.12 M(-0.9%) |
| June 2015 | - | -$15.11 M(+2.4%) | -$56.62 M(+9.6%) |
| Mar 2015 | - | -$14.76 M(+5.8%) | -$51.68 M(+8.4%) |
| Dec 2014 | -$47.67 M(+45.7%) | -$13.96 M(+9.0%) | -$47.67 M(+8.5%) |
| Sept 2014 | - | -$12.80 M(+25.9%) | -$43.95 M(+15.3%) |
| June 2014 | - | -$10.17 M(-5.4%) | -$38.13 M(+11.8%) |
| Mar 2014 | - | -$10.75 M(+5.0%) | -$34.11 M(+4.2%) |
| Dec 2013 | -$32.72 M(+388.3%) | -$10.24 M(+46.8%) | -$32.72 M(+43.0%) |
| Sept 2013 | - | -$6.98 M(+13.6%) | -$22.87 M(+23.2%) |
| June 2013 | - | -$6.14 M(-34.3%) | -$18.56 M(+49.5%) |
| Mar 2013 | - | -$9.36 M(+2275.1%) | -$12.41 M(+306.1%) |
| Dec 2012 | -$6.70 M(+14.0%) | -$394.00 K(-85.2%) | -$3.06 M(+14.8%) |
| Sept 2012 | - | -$2.66 M | -$2.66 M |
| Dec 2011 | -$5.88 M | - | - |
FAQ
- What is Immunic annual net profit?
- What is the all time high annual net income for Immunic?
- What is Immunic annual net income year-on-year change?
- What is Immunic quarterly net profit?
- What is the all time high quarterly net income for Immunic?
- What is Immunic quarterly net income year-on-year change?
- What is Immunic TTM net profit?
- What is the all time high TTM net income for Immunic?
- What is Immunic TTM net income year-on-year change?
What is Immunic annual net profit?
The current annual net income of IMUX is -$93.61 M
What is the all time high annual net income for Immunic?
Immunic all-time high annual net profit is -$5.88 M
What is Immunic annual net income year-on-year change?
Over the past year, IMUX annual net profit has changed by +$26.80 M (+22.25%)
What is Immunic quarterly net profit?
The current quarterly net income of IMUX is -$24.37 M
What is the all time high quarterly net income for Immunic?
Immunic all-time high quarterly net profit is -$394.00 K
What is Immunic quarterly net income year-on-year change?
Over the past year, IMUX quarterly net profit has changed by -$1.60 M (-7.02%)
What is Immunic TTM net profit?
The current TTM net income of IMUX is -$96.90 M
What is the all time high TTM net income for Immunic?
Immunic all-time high TTM net profit is -$2.66 M
What is Immunic TTM net income year-on-year change?
Over the past year, IMUX TTM net profit has changed by +$31.61 M (+24.60%)